These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26783047)

  • 1. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
    Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
    Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
    Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
    Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DUSP6 expression is associated with osteoporosis through the regulation of osteoclast differentiation via ERK2/Smad2 signaling.
    Zhang B; Yuan P; Xu G; Chen Z; Li Z; Ye H; Wang J; Shi P; Sun X
    Cell Death Dis; 2021 Sep; 12(9):825. PubMed ID: 34475393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
    Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
    Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CircRNA_28313/miR-195a/CSF1 axis modulates osteoclast differentiation to affect OVX-induced bone absorption in mice.
    Chen X; Ouyang Z; Shen Y; Liu B; Zhang Q; Wan L; Yin Z; Zhu W; Li S; Peng D
    RNA Biol; 2019 Sep; 16(9):1249-1262. PubMed ID: 31204558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-363-3p is activated by MYB and regulates osteoporosis pathogenesis via PTEN/PI3K/AKT signaling pathway.
    Li M; Luo R; Yang W; Zhou Z; Li C
    In Vitro Cell Dev Biol Anim; 2019 May; 55(5):376-386. PubMed ID: 31025251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis.
    Huang Y; Yang Y; Wang J; Yao S; Yao T; Xu Y; Chen Z; Yuan P; Gao J; Shen S; Ma J
    J Biol Chem; 2021; 296():100617. PubMed ID: 33811860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.
    Ji X; Chen X; Yu X
    Int J Mol Sci; 2016 Mar; 17(3):349. PubMed ID: 27005616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impdh2 deficiency suppresses osteoclastogenesis through mitochondrial oxidative phosphorylation and alleviates ovariectomy-induced osteoporosis.
    Xu C; Wei Z; Lv L; Dong X; Xia W; Xing J; Liu H; Zhao X; Liu Y; Wang W; Jiang H; Gong Y; Liu C; Xu K; Wang S; Akimoto Y; Hu Z
    Biochem Biophys Res Commun; 2024 Oct; 727():150317. PubMed ID: 38959733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
    Krzeszinski JY; Wei W; Huynh H; Jin Z; Wang X; Chang TC; Xie XJ; He L; Mangala LS; Lopez-Berestein G; Sood AK; Mendell JT; Wan Y
    Nature; 2014 Aug; 512(7515):431-5. PubMed ID: 25043055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis.
    Zhang Y; Su J; Wu S; Teng Y; Yin Z; Guo Y; Li J; Li K; Yao L; Li X
    Sci Signal; 2015 Mar; 8(369):ra31. PubMed ID: 25805889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and their roles in osteoclast differentiation.
    Xia Z; Chen C; Chen P; Xie H; Luo X
    Front Med; 2011 Dec; 5(4):414-9. PubMed ID: 22198753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
    Shi C; Qi J; Huang P; Jiang M; Zhou Q; Zhou H; Kang H; Qian N; Yang Q; Guo L; Deng L
    Bone; 2014 Nov; 68():67-75. PubMed ID: 25138550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting SAT1 prevents osteoporosis through promoting osteoclast apoptosis.
    Jin Z; Xu H; Sun X; Yan B; Wang L
    Biomed Pharmacother; 2024 Jun; 175():116732. PubMed ID: 38739990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
    Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
    Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-503 regulates osteoclastogenesis via targeting RANK.
    Chen C; Cheng P; Xie H; Zhou HD; Wu XP; Liao EY; Luo XH
    J Bone Miner Res; 2014 Feb; 29(2):338-47. PubMed ID: 23821519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation.
    Kagiya T; Nakamura S
    J Periodontal Res; 2013 Jun; 48(3):373-85. PubMed ID: 23078176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes Via Targeting Rab27a.
    Tang L; Yin Y; Liu J; Li Z; Lu X
    Cell Physiol Biochem; 2017; 43(4):1663-1672. PubMed ID: 29045940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.